经过评估，研究小组得出结论，18岁以上成年人(包括孕妇和哺乳期妇女)的安全摄入量�?毫克/天，其他人群的安全摄入量�?-7毫克/天。部分原文报道如下：

　　Following a request from the European Commission (EC), the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver a scientific opinion on the tolerable upper intake level (UL) for manganese. Systematic reviews of the literature of human and animal data were co nducted to assess evidence regarding excess manganese intake (including authorised manganese salts) and the priority adverse health effect, i.e. manganese-induced neurotoxicity. Available human and animal studies support neurotoxicity as a critical effect, however, data are not sufficient and suitable to characterise a dose�Crespo nse relatio nship and identify a reference point for manganese-induced neurotoxicity. In the absence of adequate data to establish an UL, estimated background dietary intakes (i.e. manganese intakes from natural dietary sources only) observed among high co nsumers (95th percentile) were used to provide an indication of the highest level of intake wher e there is reaso nable co nfidence on the absence of adverse effects. A safe level of intake of 8 mg/day was established for adults ��?18?years (including pregnant and lactating women) and ranged between 2 and 7 mg/day for other population groups. The application of the safe level of intake is more limited than an UL because the intake level at which the risk of adverse effects starts to increase is not defined.

　　 本文由食品伙伴网食品资讯中心编辑，供网友参考，有任何疑问，请联系news@www.sqrdapp.com、�/span>